Skip to main content

Full Schedule

Full Schedule

  • Saturday, October 15, 2022
  • 8:20 AM – 9:55 AM
    Session VI: Immune Checkpoint Inhibitors for NSCLC

    Moderator: Edward B. Garon, MD, MS – University of California, Los Angeles

    Presenter: Marina Garassino, MD – University of Chicago

    Presenter: Leena Gandhi, MD, PhD – Harvard Medical School/Dana-Farber Cancer Institute

  • 9:55 AM – 10:55 AM
    Non-CME Innovation Theater (Sponsored by AstraZeneca)
  • 9:55 AM – 10:55 AM
    Non-CME Innovation Theater (Sponsored by Regeneron)
  • 10:55 AM – 11:10 AM
    Exhibit Hall
  • 11:10 AM – 12:30 PM
    Session VII: Practical Considerations of ICIs for NSCLC

    Moderator: Edward B. Garon, MD, MS – University of California, Los Angeles

    Presenter: Mark Awad, MD, PhD (he/him/his) – Dana-Farber Cancer Institute, Harvard Medical School

    Presenter: Lyudmila Bazhenova, MD – University of California, San Diego

    Presenter: Helen J. Ross, MD – Banner MD Anderson Cancer Center

  • 12:30 PM – 1:30 PM
    ALUNBRIG® (brigatinib) for the First-Line Treatment of ALK+ mNSCLC - Clinical Case Study: Cindy -Miguel Albino, MD
  • 1:30 PM – 2:45 PM
    Session VIII: KRAS/BRAF and Other Emerging Markers

    Moderator: Edward B. Garon, MD, MS – University of California, Los Angeles

    Presenter: Lyudmila Bazhenova, MD – University of California, San Diego

  • 2:45 PM – 3:05 PM
    Exhibit Hall
  • 3:05 PM – 4:10 PM
    Session IX: SCLC Basics and Controversies

    Moderator: Edward B. Garon, MD, MS – University of California, Los Angeles

    Presenter: Kristin Higgins, MD – Winship Cancer Institute of Emory University, Dept of Radiation Oncology

    Presenter: Ticiana Leal, MD – Emory University